Charles River Laboratories International, Inc. (CRL) Financial Statements (2024 and earlier)

Company Profile

Business Address 251 BALLARDVALE ST
WILMINGTON, MA 01887
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments234242229239196164
Cash and cash equivalents234241228238195164
Short-term investments  1111 
Restricted cash and investments64300 
Receivables752650618514472430
Inventory, net of allowances, customer advances and progress billings256199186161128115
Inventory256199186161128115
Prepaid expense899497535337
Other current assets    0081
Other undisclosed current assets10185685447 
Total current assets:1,4391,2741,2011,021898827
Noncurrent Assets
Operating lease, right-of-use asset392293178140
Property, plant and equipment   1,1241,044933782
Long-term investments and receivables312     
Long-term investments312     
Intangible assets, net (including goodwill)3,8053,7732,5972,2301,8581,175
Goodwill2,8502,7121,8091,5411,247805
Intangible assets, net (excluding goodwill)9551,061788689611370
Restricted cash and investments      
Deferred income tax assets41403845
Other noncurrent assets148353353213144124
Other undisclosed noncurrent assets1,4661,291  2323
Total noncurrent assets:6,1645,7504,2903,6712,9582,103
TOTAL ASSETS:7,6037,0245,4914,6933,8562,930
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities426673479409310269
Employee-related liabilities246207159137101
Accounts payable2061981221116678
Accrued liabilities22022915013910790
Deferred revenue264220208172
Debt4350393131
Disposal group, including discontinued operation      2
Business combination, contingent consideration, liability 13     
Deferred revenue and credits118
Contract with customer, liability145
Other liabilities205138102917144
Other undisclosed current liabilities180     
Total current liabilities:1,0921,033840710558464
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,7082,6641,9301,8501,6371,114
Long-term debt, excluding current maturities     1,6271,092
Finance lease, liability 28252628
Other undisclosed long-term debt and lease obligation2,6792,3861,7481,7061022
Liabilities, other than long-term debt780583495429238287
Deferred income tax liabilities216240217167
Liability, pension and other postretirement and postemployment benefits  7573795989
Disposal group, including discontinued operation, liabilities      4
Other liabilities175243205183179195
Operating lease, liability390253156116
Business combination, contingent consideration, liability  25    
Other undisclosed noncurrent liabilities  1538337841
Total noncurrent liabilities:3,4883,3992,5072,3161,9591,402
Total liabilities:4,5794,4323,3473,0262,5181,866
Temporary equity, carrying amount425325291917
Equity
Equity, attributable to parent2,9762,5352,1151,6351,3171,045
Common stock110001
Treasury stock, value    (0)(1,660)
Additional paid in capital1,8051,7181,6281,5321,4482,560
Accumulated other comprehensive loss(262)(165)(139)(178)(173)(145)
Retained earnings1,43398162528042289
Equity, attributable to noncontrolling interest544322
Total equity:2,9812,5392,1181,6381,3201,047
TOTAL LIABILITIES AND EQUITY:7,6037,0245,4914,6933,8562,930

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues3,9763,5402,9242,6212,2661,858
Revenue, net1,858
Cost of revenue
(Cost of Goods and Services Sold)
      (1,155)
Gross profit:3,9763,5402,9242,6212,266702
Operating expenses(812)(745)(641)(607)(509)(415)
Other undisclosed operating loss(2,513)(2,206)(1,850)(1,663)(1,426) 
Operating income:651590433351331287
Nonoperating income (expense)31(35)101141439
Other nonoperating income (expense)31(36)100121339
Interest and debt expense(59)(74)(86)(61)(64)(30)
Income from continuing operations before income taxes:623481447304282297
Income tax expense(130)(82)(82)(50)(54)(171)
Income from continuing operations:493399365254227126
Income before gain (loss) on sale of properties:399365254229125
Income (loss) from discontinued operations     2(0)
Net income:493399365254229125
Net loss attributable to noncontrolling interest(6)(8)(1)(2)(2)(2)
Net income attributable to parent:486391364252226123
Preferred stock dividends and other adjustments (4)     
Other undisclosed net loss available to common stockholders, basic      
Net income available to common stockholders, diluted:483391364252226123

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:493399365254229125
Other comprehensive income (loss)24(15)(5)(25)109
Other undisclosed comprehensive income (loss)(103)(29)56(0)(1)1
Comprehensive income:392374406249203236
Comprehensive loss, net of tax, attributable to noncontrolling interest(3)(9)(2)(2)(1)(3)
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive income, net of tax, attributable to parent:389365403247202232

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: